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Background
Resistance to almost all available anti-malarials poses a
large threat for the effective control of Malaria. The only
remaining exceptions are the artemisinin (ART) deriva-
tives. However, there is now evidence that appearance of
resistance to ART either administered alone or in combi-
nation with other anti-malarials may become a reality.
Although resistance to treatment is an obstacle for
controlling the disease, in many biological models
increased drug resistance is often associated with a
biological cost. Similarly, in malaria parasites, resistance
to anti-malarial drugs such as chloroquine (CQ) [1] and
mefloquine (MF) [2] has been reported as causing a
reduction in parasite’s fitness associated with lower
asexual growth rates and/or reduced transmission
efficiency.
By using an artesunate (ATN)-resistant parasite,
AS-ATN, we have selected a parasite clone (AS-
ATNMF-1) which is resistance to the artesunate +
mefloquine (ATN + MF) version of Artemisinin Combi-
nation Therapy [3]. AS-ATNMF-1 is also resistant to
each component of the combination when administered
separately. AS-ATNMF-1 was obtained after twenty-
seven consecutive sub-inoculations of AS-ATN in mice
treated with the ATN + MF combination. Since conse-
cutive sub-inoculations into mice have been shown to
cause increased virulence in malaria parasites [4], AS-
ATN was also sub-inoculated twenty-seven times into
untreated mice in parallel. The resulting line was named
AS-ATN27P.
In order to assess the fitness cost associated with
resistance to the combination ATN + MF, AS-ATNMF-
1 parasites were grown with the AS-ATN parental clone
or with AS-ATN27P within the same host in absence of
drug pressure, for 14 days.
The proportions of each parasite parasite within were
determined along time by Proportional Sequencing [5].
Results
When in competition within the same host, AS-ATNMF-1
outgrows the unpassaged progenitor AS-ATN. However
the same is not observed when grown in competition with
the passaged parasites AS-ATN27P.
Conclusions
Our data suggest that consecutive passaging may have
induced an improvement in AS-ATNMF-1 fitness and
that resistance to the combination ATN + MF seem to
have no negative impact on the growth of these para-
sites. These results may have implications regarding the
maintenance of ACT-resistant parasites in the absence
of drug pressure.
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